Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT and Anti-PD-1 Therapy in dMMR Colorectal Adenocarcinoma Anti-PD-1 Non-Responders
NCT04729322Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Feb 2021
- Primary completion
- Dec 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Fecal Microbiota Transplantation Capsule in colorectal cancer (CRC), small intestinal cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Feb 2021; status: active, not recruiting.
02
Drugs
Fecal Microbiota Transplantation Capsule
03
Conditions
colorectal cancer (CRC)small intestinal cancer
Beyond the preview
Go deeper on NCT04729322.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04729322.